Leung Hong Man

Leung Hong Man appears in our data through filings on Dawnrays Pharmaceutical (Holdings) Ltd. shares, published by HKEX. In total, 34 filings cover trades dated from 9 December 2020 to 14 October 2026.

Every open-market trade on record is a purchase: 34 purchases worth €1.9M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 3 purchases and no sales.

Half of the purchases are above €35k and half below. Relative to company size, the median is 0.029% of market cap (3 purchases with a known value). Clusters matter here: 17 out of 34 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 15 October 2026 with an open-market purchase (€45k) in Dawnrays Pharmaceutical (Holdings) Ltd. The median gap between a trade and its publication by HKEX is 1 day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.